LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.3950
-0.0050 (-1.25%)
At close: Apr 20, 2026
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 71.8 million as of April 20, 2026. Its market cap has increased by 8.70% in one year.
Market Cap
71.80M
Enterprise Value
46.02M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.40
Market Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 71.80M, an increase of 35.53%. That is a compound annual growth rate of 13.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 71.80M | -45.10% |
| Dec 31, 2025 | 130.78M | -10.78% |
| Dec 31, 2024 | 146.59M | 204.77% |
| Dec 29, 2023 | 48.10M | -9.21% |
| Dec 11, 2023 | 52.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 106.41M |
| Immutep | 101.69M |
| Paradigm Biopharmaceuticals | 101.65M |
| Arovella Therapeutics | 97.91M |
| Botanix Pharmaceuticals | 97.57M |
| Cynata Therapeutics | 85.48M |
| Amplia Therapeutics | 84.66M |
| Radiopharm Theranostics | 72.66M |